Xiangyu Medical Reports Surge in Sales Orders, Expects H1 2023 Net Profit to Rise by 149.97%–174.97%

Sunnyou Medical Announcement on July 13: Estimated net profit attributable to shareholders for the first half of 2023 is RMB 100 million to RMB 110 million, representing a year-on-year increase of 149.97% to 174.97%. Operating revenue is RMB 320 million to RMB 350 million, representing a year-on-year increase of 44.87% to 58.45%. Sales orders grew during the reporting period.